Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation

Satoshi Higa; Akira Maesato; Sugako Ishigaki; Kazuyoshi Suenari; Yi Jen Chen; Shih Ann Chen

doi:10.1016/j.ccep.2020.11.005

Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation

Satoshi Higa, Akira Maesato, Sugako Ishigaki, Kazuyoshi Suenari, Yi Jen Chen, Shih Ann Chen

Research output: Contribution to journal › Review article › peer-review

11 Citations (Scopus)

Abstract

Risk factors including cardiometabolic and endocrine disorders have a significant impact on atrial remodeling causing atrial fibrillation (AF). Diabetes mellitus and hyperthyroidism are strong independent risk factors for AF and worsen outcomes of rhythm control strategies. An early diagnosis and intervention for these risk factors combined with rhythm control strategies may improve the overall cardiovascular mortality and morbidity. This review summarizes the current state of knowledge about the AF risk factors diabetes mellitus and thyroid disease, and discusses the impact of the modification of these risk factors on primary and secondary prevention of AF.

Original language	English
Pages (from-to)	63-75
Number of pages	13
Journal	Cardiac Electrophysiology Clinics
Volume	13
Issue number	1
DOIs	https://doi.org/10.1016/j.ccep.2020.11.005
Publication status	Published - Mar 2021

Keywords

Atrial fibrillation
Diabetes mellitus
Risk factors
Thyroid disease

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ccep.2020.11.005

Cite this

@article{c82324ce15734cebb423af2fde008e98,

title = "Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation",

abstract = "Risk factors including cardiometabolic and endocrine disorders have a significant impact on atrial remodeling causing atrial fibrillation (AF). Diabetes mellitus and hyperthyroidism are strong independent risk factors for AF and worsen outcomes of rhythm control strategies. An early diagnosis and intervention for these risk factors combined with rhythm control strategies may improve the overall cardiovascular mortality and morbidity. This review summarizes the current state of knowledge about the AF risk factors diabetes mellitus and thyroid disease, and discusses the impact of the modification of these risk factors on primary and secondary prevention of AF.",

keywords = "Atrial fibrillation, Diabetes mellitus, Risk factors, Thyroid disease",

author = "Satoshi Higa and Akira Maesato and Sugako Ishigaki and Kazuyoshi Suenari and Chen, {Yi Jen} and Chen, {Shih Ann}",

note = "Funding Information: Dr S. Higa is a consultant to Japan Life Line and Johnson & Johnson; and received speaker's honoraria from Japan Life Line, Medtronic, Abbott, Bayer, Biotronik, Boehringer-Ingelheim, Bristol-Myers, Daiichi-Sankyo Pharmaceutical Company, and Pfizer. The other authors have nothing to declare. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = mar,

doi = "10.1016/j.ccep.2020.11.005",

language = "English",

volume = "13",

pages = "63--75",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",

publisher = "W.B. Saunders",

number = "1",

}

TY - JOUR

T1 - Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation

AU - Higa, Satoshi

AU - Maesato, Akira

AU - Ishigaki, Sugako

AU - Suenari, Kazuyoshi

AU - Chen, Yi Jen

AU - Chen, Shih Ann

N1 - Funding Information: Dr S. Higa is a consultant to Japan Life Line and Johnson & Johnson; and received speaker's honoraria from Japan Life Line, Medtronic, Abbott, Bayer, Biotronik, Boehringer-Ingelheim, Bristol-Myers, Daiichi-Sankyo Pharmaceutical Company, and Pfizer. The other authors have nothing to declare. Publisher Copyright: © 2020 Elsevier Inc.

PY - 2021/3

Y1 - 2021/3

N2 - Risk factors including cardiometabolic and endocrine disorders have a significant impact on atrial remodeling causing atrial fibrillation (AF). Diabetes mellitus and hyperthyroidism are strong independent risk factors for AF and worsen outcomes of rhythm control strategies. An early diagnosis and intervention for these risk factors combined with rhythm control strategies may improve the overall cardiovascular mortality and morbidity. This review summarizes the current state of knowledge about the AF risk factors diabetes mellitus and thyroid disease, and discusses the impact of the modification of these risk factors on primary and secondary prevention of AF.

AB - Risk factors including cardiometabolic and endocrine disorders have a significant impact on atrial remodeling causing atrial fibrillation (AF). Diabetes mellitus and hyperthyroidism are strong independent risk factors for AF and worsen outcomes of rhythm control strategies. An early diagnosis and intervention for these risk factors combined with rhythm control strategies may improve the overall cardiovascular mortality and morbidity. This review summarizes the current state of knowledge about the AF risk factors diabetes mellitus and thyroid disease, and discusses the impact of the modification of these risk factors on primary and secondary prevention of AF.

KW - Atrial fibrillation

KW - Diabetes mellitus

KW - Risk factors

KW - Thyroid disease

UR - http://www.scopus.com/inward/record.url?scp=85099215316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099215316&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2020.11.005

DO - 10.1016/j.ccep.2020.11.005

M3 - Review article

C2 - 33516408

AN - SCOPUS:85099215316

SN - 1877-9182

VL - 13

SP - 63

EP - 75

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

IS - 1

ER -

Diabetes and Endocrine Disorders (Hyperthyroidism/Hypothyroidism) as Risk Factors for Atrial Fibrillation

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this